Molecular Biology Conference
A novel COVID-19 vaccine using modified bacterial DNA Experimental vaccine based on altered plasmid DNA produced antibody response in mice that effectively blocked cell infection across all variants of concern tested. Researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods. Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods. Their findings publish in the July 21, 2022 online issue of PLOS Pathogens . The research involved building plasmids genetically altered to contain bits of genetic material specifically intended to target a vulnerability in the SARS-CoV-2 virus'...